This editorial presents some of the latest evidence to support the antivirulence approach, highlighting at the same time some of the issues that need to be considered when evaluating antivirulence drugs.
How can we ensure products remain pathogen free? In this editorial, the authors discuss the most common causes of food-borne illnesses, methods by which contamination is traditionally detected and what current research has to offer, specifically in the field of nanoscience.
In this original research article, the authors determine the structural contributions of a compound set containing inhibitors of bacterial enzyme FabI.
Despite an urgent need for a universal flu vaccine there is no such vaccine in the market and no regulatory guideline for its approval. This special report from Future Virology proposes a stepwise process for regulatory and marketing approval for such a vaccine and discusses the epitope-based vaccine candidate Multimeric-001 (M-001).
In this editorial the author examines the initiatives taken by Drugs for Neglected Diseases (DNDi) and Medicines Patent Pool (MPP) organizations to improve access to pan-genotypic hepatitis C treatment.
In this editorial the authors discuss conventional diagnostic approaches and alternative diagnostic tests, which could be used in the future.
This review delves into new diagnostic Aspergillus spp. procedures, in addition, the authors look at intrinsic antifungal resistance and mechanisms of secondary resistance to triazoles in A. fumigatus.
Could nanoconstructs be utilized to fight infection? This Editorial discusses the potential of photoactivatable nanodrugs to overcome the growing problem of acquired antibiotic resistance in bacteria as well as the intrinsic resistance of biofilm-associated infections.
In this study, the authors investigate the miRNA expression profile of Schistosoma japonicum in response to atesunate providing an overview of the complex mechanism.